TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18312059

Group type: EXPERIMENTAL
Intervention: High maternal fetal attachment (measured by MAAS)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Interpersonal relationship dissatisfaction (measured by DAS)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Incompetent cervix (obstetric complication)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: EPDS score of 11 or greater
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: DSM-IV criteria for major depressive disorder
Number of subjects: 129
Study: 16424842

Group type: EXPERIMENTAL
Intervention: Single‐atrial cannulation (group A)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Single‐atrial cannulation with intraoperative hemofiltration (group B)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bicaval cannulation (group C)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 12719782

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg daily
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 11056099

Group type: EXPERIMENTAL
Intervention: Second-phase pulse duration of 1 ms
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Second-phase pulse duration from 2 to 18 ms
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Phase 2 energy
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Normalized average current during phase 2
Number of subjects: 36
Study: 8853248

Group type: COMPARATOR
Intervention: Omeprazole 40 mg daily
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg daily plus repeated laser photocoagulation
Number of subjects: 8
Study: 1847704

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril 75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril with Dexamethasone (DXM) 25 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Captopril with Dexamethasone (DXM) 75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indomethacin with captopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study: 6294263

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 75 mg/kg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 50 mg/kg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (both dosages)
Number of subjects: 17
Study: 29740015

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (ALA) + sodium ferrous citrate (SFC) supplementation
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 9
Study: 26654212

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy for perinatal depression (MBCT-PD)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 86
Study: 25113509

Group type: EXPERIMENTAL
Intervention: 4 mL of 0.33% ropivacaine and normal saline with epinephrine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline with epinephrine
Number of subjects: 50
Study: 22455835

Group type: EXPERIMENTAL
Intervention: OCD treatment response
Number of subjects: 76
Study: 21595143

Group type: EXPERIMENTAL
Intervention: Orthopedic treatment including Minimal invasive Therapy (MIT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naturopathic 'complex'-treatment
Number of subjects: 0
Study: 18814453

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol pMDI
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Budesonide pMDI
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1076
Study: 16155268

Group type: EXPERIMENTAL
Intervention: 30 g resistant starch/d
Number of subjects: 10
Study: 12947272

Group type: EXPERIMENTAL
Intervention: New strategy using transcutaneous oxygen pressure (tcPo(2)) and toe blood pressure (TP) measurements
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional strategy using clinical judgment and ankle pressure
Number of subjects: 96
Study: 10814606

Group type: EXPERIMENTAL
Intervention: High-dose ATP infusion (75 microg.min(‐1).kg(‐1))
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-dose ATP infusion (37-50 microg.min(‐1).kg(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control NSCLC patients (N=13) and healthy subjects (N=11)
Number of subjects: 12
Study: 9015906

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg o.m. plus clarithromycin 500 mg t.i.d. for 14 days (group L30)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg b.i.d. plus clarithromycin 500 mg t.i.d. for 14 days (group L60)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (L30 and L60)
Number of subjects: 26
Study: 2056290

Group type: EXPERIMENTAL
Intervention: Home air-fluidized bed therapy
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 112
Study: 6616404

Group type: EXPERIMENTAL
Intervention: DTIC plus hyperthermia (42 degrees C)
Number of subjects: 53

Group type: COMPARATOR
Intervention: DTIC at 37 degrees C
Number of subjects: 53

Group type: COMPARATOR
Intervention: Hyperthermia alone (42 degrees C)
Number of subjects: 53

Group type: COMPARATOR
Intervention: DTIC at 42 degrees C
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: DTIC plus hyperthermia
Number of subjects: 53
Study: 31111509

Group type: EXPERIMENTAL
Intervention: Two €5 incentives (at the beginning and at the end of screening)
Number of subjects: 1652

Group type: COMPARATOR
Intervention: One €10 incentive (upon completion of screening)
Number of subjects: 1652
Study: 28539177

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens/bazedoxifene (CE/BZA)
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Clinical parameters (vaginal pH, parabasal/superficial cells)
Number of subjects: 664
Study: 27284561

Group type: EXPERIMENTAL
Intervention: Green tea chewing gum
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo chewing gum
Number of subjects: 45
Study: 25060107

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN) protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 19294953

Group type: COMPARATOR
Intervention: School-based intervention program (N = 41) consisting of four 50-minute classes over a 4-week period educating on healthy lifestyle based on cognitive-behavior therapy framework.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control class (CAU, N = 40)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: School-based intervention program for adolescents with delayed sleep timing (DST; Program, N = 21)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control class for adolescents with delayed sleep timing (DST; CAU, N = 15)
Number of subjects: 81
Study: 17466242

Group type: EXPERIMENTAL
Intervention: Lateral hop test
Number of subjects: 29

Group type: COMPARATOR
Intervention: Forward hop test
Number of subjects: 29
Study: 11008725

Group type: EXPERIMENTAL
Intervention: 0.2% GTN ointment
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 10-mg nitroglycerin patch
Number of subjects: 37

Group type: COMPARATOR
Intervention: Surgical treatment (Control group C)
Number of subjects: 37
Study: 9366699

Group type: EXPERIMENTAL
Intervention: Ofloxacin (adults, 0.5 mL; children, 0.25 mL) twice daily for 10 days
Number of subjects: 601

Group type: COMPARATOR
Intervention: Cortisporin (adults, 0.2 mL; children, 0.15 mL) 4 times daily for 10 days
Number of subjects: 601
Study: 1531118

Group type: EXPERIMENTAL
Intervention: Total intravenous maintenance of anaesthesia with an infusion of propofol and increments of alfentanil (Group P)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Inhalational maintenance of anaesthesia with nitrous oxide and enflurane (Group E)
Number of subjects: 80
Study: 3158128

Group type: EXPERIMENTAL
Intervention: Lidocaine (2 mg/min intravenous infusion following an initial bolus of 200 mg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No lidocaine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Lidocaine and No lidocaine
Number of subjects: 49
Study: 31705526

Group type: EXPERIMENTAL
Intervention: Guselkumab 100 mg by subcutaneous injection
Number of subjects: 119

Group type: COMPARATOR
Intervention: Fumaric acid esters (FAE)
Number of subjects: 119
Study: 29621660

Group type: EXPERIMENTAL
Intervention: Plantar perception training using a hardness discrimination task
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Plantar perception training
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group performing the same task without hardness discrimination
Number of subjects: 62
Study: 26453914

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (AsA) 500 mg; α-tocopherol 300 IU
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study: 24885600

Group type: EXPERIMENTAL
Intervention: High-dose vitamin C infusion plus oral administration of vitamin E during angioplasty, followed by oral doses of vitamins C and E for 84 days
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo during angioplasty, followed by placebo for 84 days
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: High-dose vitamin C infusion plus oral administration of vitamin E
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 22228118

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTX)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 27
Study: 20413269

Group type: EXPERIMENTAL
Intervention: Distraction osteogenesis (DO)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Conventional orthognathic surgery (CO)
Number of subjects: 21
Study: 18606481

Group type: EXPERIMENTAL
Intervention: 9vPnC‐MnCC (CRM197‐conjugated pneumococcal serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F and meningococcal C polysaccharides) given in three doses (3, 4, and 5 months)
Number of subjects: 223

Group type: COMPARATOR
Intervention: 9vPnC‐MnCC (CRM197‐conjugated pneumococcal serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F and meningococcal C polysaccharides) given in two doses (3 and 5 months)
Number of subjects: 223
Study: 15811481

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg TID
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo TID
Number of subjects: 51
Study: 12093340

Group type: EXPERIMENTAL
Intervention: Promogran (n = 138)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Moistened gauze (control group; n = 138)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Promogran (n = 95)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Moistened gauze (control group; n = 89)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Moistened gauze (control group; n = 49)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Promogran (n = 43)
Number of subjects: 276
Study: 10505830

Group type: EXPERIMENTAL
Intervention: Light reduction intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (ambient light exposure)
Number of subjects: 0
Study: 8565755

Group type: EXPERIMENTAL
Intervention: Endoscopic variceal sclerotherapy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no sclerotherapy)
Number of subjects: 48
Study: 2021720

Group type: EXPERIMENTAL
Intervention: Radiographers' assessments using a four point triage scheme (normal, abnormal, insignificantly abnormal, or further advice required)
Number of subjects: 3394

Group type: EXPERIMENTAL
Intervention: Radiographers' assessments
Number of subjects: 3394
Study: 31709452

Group type: EXPERIMENTAL
Intervention: Enriched environmental programme
Number of subjects: 92

Group type: COMPARATOR
Intervention: Usual ward activity
Number of subjects: 92
Study: 30484021

Group type: EXPERIMENTAL
Intervention: Wet-cupping therapy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional therapy (rest and oral medications)
Number of subjects: 180
Study: 28974480

Group type: EXPERIMENTAL
Intervention: Plasma PFAS concentrations (PFOS and PFOA)
Number of subjects: 957
Study: 23993038

Group type: EXPERIMENTAL
Intervention: Right-sided paresis group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Left-sided paresis group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Historical control subjects
Number of subjects: 42
Study: 23601029

Group type: EXPERIMENTAL
Intervention: Lingual mucosa graft urethroplasty
Number of subjects: 30

Group type: COMPARATOR
Intervention: Buccal mucosa graft urethroplasty
Number of subjects: 30
Study: 21425572

Group type: EXPERIMENTAL
Intervention: Xiongshao Capsule (XSC)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Xuefu Zhuyu Capsule (Control)
Number of subjects: 240
Study: 21714585

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg (group R)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg plus fenofibrate 200 mg (group RF)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg plus omega 3 fatty acids 2 g daily (group RΩ)
Number of subjects: 90
Study: 17402355

Group type: EXPERIMENTAL
Intervention: Intensive treatment group using a portable computer for daily contact with heart failure clinic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual ambulatory care
Number of subjects: 60
Study: 16215713

Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg/day)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg/day) + Metoprolol (50 mg/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: All drug therapy groups
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 39
Study: 11897539

Group type: EXPERIMENTAL
Intervention: Schizophrenia patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 25
Study: 10543315

Group type: EXPERIMENTAL
Intervention: PNU-142633F 1.0 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: PNU-142633F 3.0 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: PNU-142633F 30 mg
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: PNU-142633F 100 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 7587604

Group type: EXPERIMENTAL
Intervention: Combined therapy with glurenorm and insulin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Glurenorm
Number of subjects: 33
Study: 2339203

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (marine oil capsules)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aspirin (daily dosages increasing from 162 to 2600 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6106735

Group type: EXPERIMENTAL
Intervention: 14-valent pneumococcal polysaccharide vaccine
Number of subjects: 827

Group type: COMPARATOR
Intervention: Control vaccine (Haemophilus influenzae type b capsular polysaccharide)
Number of subjects: 827
Study: 31437191

Group type: EXPERIMENTAL
Intervention: Heart rate measurements during low-intensity resistance exercises (half squat, 45 inclined leg press, leg extension, horizontal bench press, 45 inclined bench press, lat pull down, triceps extension, biceps curl)
Number of subjects: 56
Study: 28540899

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 193

Group type: COMPARATOR
Intervention: Women
Number of subjects: 193
Study: 25791863

Group type: EXPERIMENTAL
Intervention: Pistachio-supplemented diet (PD, 57 g/d of pistachios daily)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Pistachio-supplemented diet (PD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control diet (CD)
Number of subjects: 54
Study: 22920910

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 21098143

Group type: EXPERIMENTAL
Intervention: 5 mg zolpidem alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 mg zolpidem after 15 days of 400 mg carbamazepine
Number of subjects: 0
Study: 19830963

Group type: EXPERIMENTAL
Intervention: ScotchBond Multi‐Purpose (MP, 3M ESPE)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Experimental adhesive (EX, Vericom) with retention form
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: All adhesives with retention form
Number of subjects: 39

Group type: COMPARATOR
Intervention: Adper Prompt (AP, 3M ESPE)
Number of subjects: 39
Study: 16918657

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.4 mg x kg(‐1) administered i.v. before intubation (Group R, n = 59)
Number of subjects: 119

Group type: COMPARATOR
Intervention: No muscle relaxant (Group C, n = 60)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 119
Study: 15486330

Group type: EXPERIMENTAL
Intervention: Intervention (structured nurse assessment, education, treatment recommendations)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 146
Study: 11374206

Group type: EXPERIMENTAL
Intervention: Positive verbal label
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative verbal label
Number of subjects: 0
Study: 9378840

Group type: EXPERIMENTAL
Intervention: Bolus injection of sinistrin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Bolus dose followed by a 6-hour infusion of sinistrin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Two-point method after bolus
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: D/AUC method with extrapolation to infinity
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: UV/P method
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rinf/P method
Number of subjects: 6
Study: 8475837

Group type: EXPERIMENTAL
Intervention: Postoperative subconjunctival 5-fluorouracil (5-FU) injections
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 263
Study: 3692037

Group type: EXPERIMENTAL
Intervention: Screening genogram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no screening genogram)
Number of subjects: 0
Study: 29446195

Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing and cognitive-behavioural therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer term motivational interviewing and cognitive-behavioural therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 0
Study: 26298842

Group type: EXPERIMENTAL
Intervention: Documentary film about schizophrenia (Film group)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 49
Study: 24873088

Group type: EXPERIMENTAL
Intervention: Titanium Elastic Nail System (TENS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Stainless Steel Elastic Nail System (SSEN)
Number of subjects: 35
Study: 21801476

Group type: EXPERIMENTAL
Intervention: B-vitamins (5-methyl-THF (560 μg); vitamin B₆ (3 mg); vitamin B₁₂ (20 μg))
Number of subjects: 2501

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (600 mg of EPA and DHA at a ratio of 2:1)
Number of subjects: 2501

Group type: EXPERIMENTAL
Intervention: Both B-vitamins and n-3 fatty acids
Number of subjects: 2501

Group type: COMPARATOR
Intervention: Placebo for B-vitamins and n-3 fatty acids
Number of subjects: 2501

Group type: COMPARATOR
Intervention: Placebo for both treatments
Number of subjects: 2501
Study: 20368566

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (40,000 U weekly during and after chemotherapy)
Number of subjects: 1379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1379
Study: 18394661

Group type: EXPERIMENTAL
Intervention: Anodal tDCS combined with d-cycloserine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 16084429

Group type: EXPERIMENTAL
Intervention: 2 compartment model (2C)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 3 compartment model (3C)
Number of subjects: 77
Study: 12196498

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 699

Group type: COMPARATOR
Intervention: Control
Number of subjects: 699
Study: 9987699

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 7778543

Group type: EXPERIMENTAL
Intervention: Beta-blocker treatment
Number of subjects: 2800
Study: 2320062

Group type: COMPARATOR
Intervention: Erythromycin (200 mg, intravenous)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral erythromycin (250 mg three times a day for four weeks)
Number of subjects: 10
Study: 7351282

Group type: EXPERIMENTAL
Intervention: Diphenoxylate with atropine (Lomotil)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30170430

Group type: EXPERIMENTAL
Intervention: 35% phosphoric acid etching
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 40% phosphoric acid etching
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 45% phosphoric acid etching
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2 adhesive
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Scanning electron microscopy (SEM) analysis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Comparison of bond strength across fluorosis levels
Number of subjects: 120
Study: 27606611

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5FU)
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Beta Radiation
Number of subjects: 301
Study: 23999198

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8 mg and 3.0 mg
Number of subjects: 49
Study: 23326985

Group type: EXPERIMENTAL
Intervention: Custom-made aluminum splint
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional aluminum splint
Number of subjects: 60
Study: 20034629

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 14238
Study: 18772279

Group type: EXPERIMENTAL
Intervention: Computerized visual feedback
Number of subjects: 12

Group type: COMPARATOR
Intervention: Verbal instructions by the therapist
Number of subjects: 12

Group type: COMPARATOR
Intervention: No form of feedback
Number of subjects: 12
Study: 15962332

Group type: EXPERIMENTAL
Intervention: Endurance training program (12-week supervised rehabilitation program, cycle exercise at 70% peak work rate, upper-body weight-lifting at 50% maximum capacity)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20